Fatigue, a common symptom reported in clinical practice, often poses a diagnostic challenge due to its multifactorial etiology. A thorough understanding of its underlying mechanisms and a comprehensive clinical approach are crucial for effective management.
Fatigue can be classified into physical and mental, each with distinct pathophysiological mechanisms. Physical fatigue, often resulting from strenuous physical activity, is associated with muscle weakness and a lack of energy. Mental fatigue, on the other hand, manifests as difficulty in concentrating, memory impairment, and a decreased mental stamina. It is important to distinguish between the two as their management strategies differ significantly.
A detailed history and physical examination form the cornerstone of fatigue evaluation. The history should encompass the onset, duration, severity, and impact of fatigue on daily activities. Associated symptoms, psychosocial factors, and past medical history should also be considered. Physical examination should focus on signs of systemic diseases that could manifest as fatigue. Laboratory investigations are guided by clinical suspicion and may include complete blood count, thyroid function tests, and markers of inflammation.
Management of fatigue should be individualized, addressing the underlying cause and associated symptoms. Non-pharmacological interventions, including lifestyle modifications and cognitive-behavioral therapy, form the first line of management. Pharmacological therapy, such as stimulants, may be considered in refractory cases or when an underlying medical condition necessitates it.
Fatigue, while common, can be a manifestation of underlying serious conditions. A comprehensive clinical approach, encompassing a thorough history, physical examination, and targeted investigations, is essential in identifying the etiology. Management should be individualized, addressing the root cause and improving the patient's quality of life. Ongoing research in this field promises to enhance our understanding and management of this complex symptom.
1.
Does Maintenance Therapy Extend Life in mCRC?
2.
What does it mean for Biden's prostate cancer to be 'aggressive'? A urologic surgeon explains
3.
Cancer Treatment Ups CV Risk; Therapy's Next Big Thing; Nude Photos Settlement
4.
Pharyngoesophageal junction cancer is not a good candidate for endoscopically assisted transoral surgery.
5.
Study Finds Actionable Mutations in Brain Mets of Breast Cancer Patients
1.
What Is May-Hegglin Anomaly? Understanding this Rare Blood Disorder
2.
Hypogammaglobulinemia: A Comprehensive Guide for Patients and Caregivers
3.
Personalized Survivorship Navigation in Precision Cancer Care
4.
Hematopoietic Stem Cell Exhaustion in Blood Disorders
5.
Hematopoietic Clonal Competition in Blood Disorders
1.
International Conference on Oncology, Cardiology and Critical Care Policy
2.
International Conference on Innovations in Critical Care for Oncology and Cardiology
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Cancer Nursing and Hematology Support
1.
Advances in Modern Cancer Treatment
2.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part I
3.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII
4.
Early Warning Signs of Cancer
5.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Important Points to Know
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation